Click on the links below to access the satellite invitations. The following satellites are listed in alphabetical order (by company).
Achieving new standards in bone metastases treatment
Personalising medicine for GI cancers
HER2-targeted therapy for metastatic breast cancer: A multidisciplinary approach
Click here to view the satellite invitation
New evidence, new standards? Redefining treatment selection in mRCC
Click here to view the satellite invitation
Managing GI malignancies with targeted therapeutics; focus on NET, GIST, and HCC
Click here to view the satellite invitation
Targeting advanced breast cancer at the molecular level – translating emerging data into clinical practice
Click here to view the satellite invitation
Timely interventions in metastatic RCC: Treatment choices in an intricate landscape
Click here to view the satellite invitation
Beyond convention: New perspectives in NSCLC
Click here to view the satellite invitation
Clinical advances in HER2-positive breast cancer: Overcoming challenges with patients in mind
Click here to view the satellite invitation
Individualised treatment strategies to maximise survival in mCRC
Click here to view the satellite invitation
Integrating bevacizumab into clinical practice in ovarian cancer
Click here to view the satellite invitation
Personalising therapy in metastatic melanoma
Click here to view the satellite invitation
Turning today’s challenges in tomorrow’s success
Click here to view the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.